𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells

✍ Scribed by Kevin Atkins; Janice E. Berry; Wei-Zhen Zhang; John F. Harris; Ann F. Chambers; Robert U. Simpson; Martha J. Somerman


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
272 KB
Volume
175
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Promyelocytic leukemia HL-60 cells promoted by PMA to differentiate along the monocyte pathway adhere to tissue culture plates. To explore the regulation of adhesion molecules in cells promoted to differentiate, the expression and secretion of osteopontin (OPN) and expression of associated cell surface receptors, CD44 and integrin subunits a v , b 3 , b 1 , were examined. Results were as follows: 1) PMA induced OPN mRNA and OPN secretion into media; 2) untreated cells expressed b 1 and CD44 mRNA, and PMA induced a v and b 3 mRNA and increased b 1 and CD44 mRNA expression; 3) PMA increased levels of a v , b 3 , b 1 and CD44 protein on the cell surface; and 4) retinoic acid, which promotes granulocytic differentiation of HL-60 cells, did not affect OPN, a v , b 3 , b 1 , or CD44 mRNA or protein expression. These data suggest that induction of OPN and associated receptors may play a role during monocytic differentiation of HL-60 cells.


📜 SIMILAR VOLUMES


Expression of WASP and Scar1/WAVE1 actin
✍ Launay, Sophie ;Brown, Geoffrey ;Machesky, Laura M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

## Abstract The Wiskott‐Aldrich Syndrome (WAS) is a disease associated with mutations in the WAS gene and characterised by developmental defects in haematopoietic cells such as myeloid cells. The Wiskott‐Aldrich Syndrome protein (WASP)‐family includes Scar1 and WASP, which are key regulators of act

Heat shock protein is a unique marker of
✍ Neil L. Spector; Colleen Ryan; William Samson; Herbert Levine; Lee M. Nadler; A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 751 KB

Prior to morphologic and functional maturation, terminally differentiating hematopoietic cells first exit the cell cycle and undergo growth arrest. Relatively little is known about which molecules regulate differentiation-induced growth arrest. In the present report, we sought to determine whether t

Modulation of PAI-1 and proMMP-9 synthes
✍ Franck Peiretti; Denis Bernot; Sophie Lopez; Bernadette Bonardo; Paule Deprez-Be 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

## Abstract During phorbol ester‐induced differentiation of HL‐60 monocytic cells, tumor necrosis factorα (TNFα) synthesis and secretion are increased, which contributes to the autocrine regulation of TNFα‐responsive genes. We investigated how, during phorbol ester‐induced differentiation of HL‐60

Coordinate expression of c-myc, c-myb, a
✍ Zamir S. Brelvi; George P. Studzinski 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 889 KB

The expression of oncogenes c-myc and c-myb in human leukemic cells HL 60 was compared to the expression of histone H4 gene, known to be cell-cycle dependent. Steady-state levels of mRNA transcribed from these genes were determined by simultaneous hybridization of Northern transfers with four probes

Inhibition of p38MAP kinase potentiates
✍ Xuening Wang; George P. Studzinski 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract Monocytic differentiation of HL60 cells induced by 1,25‐dihydroxyvitamin D~3~ (1,25 D~3~) has been recently shown (Exp Cell Res 258, 425, 2000) to be enhanced by an exposure to SB203580 or to SB202190, specific inhibitors of p38MAP kinase, with concomitant up‐regulation of the c‐jun N t

Resistance to 1,25D-induced differentiat
✍ Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o